An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix in Manitoba, Canada

Trial Profile

An Observational Retrospective Database Analysis to Estimate the Risk of Multiple Sclerosis Following Vaccination With Arepanrix in Manitoba, Canada

Completed
Phase of Trial: Phase IV

Latest Information Update: 25 May 2016

At a glance

  • Drugs Influenza A virus H1N1 vaccines (Primary)
  • Indications Influenza A virus H1N1 subtype
  • Focus Adverse reactions
  • Acronyms H1N1-014VS
  • Most Recent Events

    • 10 May 2016 Status changed from active, no longer recruiting to completed.
    • 25 Feb 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top